Rx (Prescription Medicine)
USD $ 120.00
Doceaqualip 80mg 注射液是一种用于治疗特定类型癌症的靶向疗法。其活性成分Docetaxel是一种强效化疗药物，通过干扰癌细胞的生长与分裂起作用。Docetaxel属于紫杉醇类药物。它通过稳定微管——细胞内部结构的关键组成部分——从而阻止微管的降解，使细胞分裂停止，最终导致快速分裂的癌细胞凋亡（程序性细胞死亡）。
Doceaqualip 80mg 注射液用于治疗多种癌症，包括乳腺癌、非小细胞肺癌、前列腺癌、胃腺癌以及头颈部癌症。Doceaqualip 80mg 注射液的剂量和给药方式由合格的医疗专业人员根据具体癌症类型、分期、患者整体健康状况及治疗反应确定。通常采用静脉给药。
常见不良反应可能包括疲劳、恶心、呕吐、腹泻、脱发以及血细胞计数下降。更严重的不良反应也可能发生，患者应立即向医生报告任何异常症状。Doceaqualip 80mg 注射液应储存在室温、避光处，且不可冷冻。严格遵循医疗提供者的指示至关重要。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Docetaxel 80 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
